TWST - Twist Bioscience Corporation

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 980.64M
Enterprise value 684.21M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.94
Price/book (mrq)1.35
Enterprise value/revenue 3.00
Enterprise value/EBITDA -3.60

Trading information

Stock price history

Beta (5Y monthly) 1.16
52-week change 3-35.92%
S&P500 52-week change 310.08%
52-week high 358.76
52-week low 311.46
50-day moving average 313.96
200-day moving average 324.73

Share statistics

Avg vol (3-month) 31.44M
Avg vol (10-day) 31.22M
Shares outstanding 557.15M
Implied shares outstanding 6N/A
Float 856.42M
% held by insiders 11.44%
% held by institutions 1109.36%
Shares short (14 May 2023) 413.83M
Short ratio (14 May 2023) 49.22
Short % of float (14 May 2023) 427.72%
Short % of shares outstanding (14 May 2023) 424.21%
Shares short (prior month 13 Apr 2023) 412.09M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 29 Sept 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin -93.32%
Operating margin (ttm)-102.50%

Management effectiveness

Return on assets (ttm)-15.56%
Return on equity (ttm)-27.13%

Income statement

Revenue (ttm)227.84M
Revenue per share (ttm)4.04
Quarterly revenue growth (yoy)25.00%
Gross profit (ttm)84.23M
EBITDA -211.82M
Net income avi to common (ttm)-212.61M
Diluted EPS (ttm)-3.99
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)387.66M
Total cash per share (mrq)6.78
Total debt (mrq)91.22M
Total debt/equity (mrq)12.96
Current ratio (mrq)6.78
Book value per share (mrq)12.33

Cash flow statement

Operating cash flow (ttm)-133.75M
Levered free cash flow (ttm)-178.06M